Key Segmentation
By Test Type
-
ELISA-Based Tests
-
RT-PCR-Based Tests
-
Rapid Antigen/Antibody Tests
-
Others
By Pathogen
-
Dengue
-
Zika
-
Chikungunya
-
West Nile Virus
-
Yellow Fever
-
Others
By End Use
-
Hospitals
-
Diagnostic Laboratories
-
Research & Academic Institutes
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
North America dominated the Arbovirus Testing Market in 2025 with approximately 42% of global revenues.
Dengue dominated the market in 2025 driven by its status as the world's most prevalent arboviral disease affecting.
ELISA-Based Tests dominated the market in 2025 with approximately 49% of revenues.
The Arbovirus Testing Market was valued at USD 1.31 billion in 2025.
The Arbovirus Testing Market is expected to grow at a CAGR of 4.36% from 2026 to 2035.